4i5p
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Selective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein Phosphorylation in Rat Brain== | ==Selective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein Phosphorylation in Rat Brain== | ||
| - | <StructureSection load='4i5p' size='340' side='right' caption='[[4i5p]], [[Resolution|resolution]] 1.74Å' scene=''> | + | <StructureSection load='4i5p' size='340' side='right'caption='[[4i5p]], [[Resolution|resolution]] 1.74Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4i5p]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4i5p]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4I5P OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4I5P FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=1D1:(7R)-8-CYCLOPENTYL-7-ETHYL-5-METHYL-2-(1H-PYRROL-2-YL)-7,8-DIHYDROPTERIDIN-6(5H)-ONE'>1D1</scene | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=1D1:(7R)-8-CYCLOPENTYL-7-ETHYL-5-METHYL-2-(1H-PYRROL-2-YL)-7,8-DIHYDROPTERIDIN-6(5H)-ONE'>1D1</scene></td></tr> |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4i5p FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4i5p OCA], [https://pdbe.org/4i5p PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4i5p RCSB], [https://www.ebi.ac.uk/pdbsum/4i5p PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4i5p ProSAT]</span></td></tr> | |
| - | + | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/PLK2_HUMAN PLK2_HUMAN] Tumor suppressor serine/threonine-protein kinase involved in synaptic plasticity, centriole duplication and G1/S phase transition. Polo-like kinases act by binding and phosphorylating proteins are that already phosphorylated on a specific motif recognized by the POLO box domains. Phosphorylates CENPJ, NPM1, RAPGEF2, RASGRF1, SNCA, SIPA1L1 and SYNGAP1. Plays a key role in synaptic plasticity and memory by regulating the Ras and Rap protein signaling: required for overactivity-dependent spine remodeling by phosphorylating the Ras activator RASGRF1 and the Rap inhibitor SIPA1L1 leading to their degradation by the proteasome. Conversely, phosphorylates the Rap activator RAPGEF2 and the Ras inhibitor SYNGAP1, promoting their activity. Also regulates synaptic plasticity independently of kinase activity, via its interaction with NSF that disrupts the interaction between NSF and the GRIA2 subunit of AMPARs, leading to a rapid rundown of AMPAR-mediated current that occludes long term depression. Required for procentriole formation and centriole duplication by phosphorylating CENPJ and NPM1, respectively. Its induction by p53/TP53 suggests that it may participate in the mitotic checkpoint following stress.<ref>PMID:15242618</ref> <ref>PMID:19001868</ref> <ref>PMID:20531387</ref> <ref>PMID:20352051</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 22: | Line 20: | ||
==See Also== | ==See Also== | ||
| - | *[[Serine/threonine protein kinase|Serine/threonine protein kinase]] | + | *[[Serine/threonine protein kinase 3D structures|Serine/threonine protein kinase 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: Adler | + | [[Category: Adler M]] |
| - | [[Category: Aubele | + | [[Category: Aubele DL]] |
| - | [[Category: Beroza | + | [[Category: Beroza P]] |
| - | [[Category: Bowers | + | [[Category: Bowers S]] |
| - | [[Category: Galemmo | + | [[Category: Galemmo Jr RA]] |
| - | [[Category: Hom | + | [[Category: Hom RK]] |
| - | [[Category: Pan | + | [[Category: Pan H]] |
| - | [[Category: Truong | + | [[Category: Truong AP]] |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Revision as of 08:43, 9 November 2022
Selective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein Phosphorylation in Rat Brain
| |||||||||||
Categories: Homo sapiens | Large Structures | Adler M | Aubele DL | Beroza P | Bowers S | Galemmo Jr RA | Hom RK | Pan H | Truong AP
